PMID- 9104557 OWN - NLM STAT- MEDLINE DCOM- 19970612 LR - 20190831 IS - 0425-1644 (Print) IS - 0425-1644 (Linking) VI - 29 IP - 2 DP - 1997 Mar TI - Nitric oxide production by equine articular cells in vitro. PG - 98-102 AB - Recent research in several species has suggested nitric oxide (NO) as a mediator of articular cartilage damage and an inhibitor of cartilage matrix neosynthesis. This study investigated NO production by cultured equine articular chondrocytes in response to 2 arthritogenic molecules, namely lipopolysaccharide (LPS) and interleukin-1 beta (IL-1 beta), and compared NO production by cultured equine synoviocytes stimulated with LPS. Synoviocytes exhibited a low basal level of NO synthesis (measured as nitrite, a NO metabolite) that was neither significantly increased nor decreased by exposure to LPS. Basal NO synthesis by synoviocytes was not significantly reduced by competitive inhibitors of nitric oxide synthase (NOS). In contrast, chondrocytes treated with LPS or IL-1 beta synthesised nitrite in a dose-related manner. Inhibitors of NOS suppressed nitrite production to below the basal levels of release of unstimulated cells. Dexamethasone, an inhibitor of induction of the inducible isoform of NOS (iNOS), reduced nitrite synthesis by LPS-stimulated chondrocytes. Western blot analysis revealed expression, in response to LPS, of protein in the same molecular weight range as iNOS identified in other species. This work demonstrates that equine chondrocytes have the capacity to synthesise NO, although its exact roles in cartilage metabolism have yet to be determined. FAU - Frean, S P AU - Frean SP AD - Department of Veterinary Basic Sciences, Royal Veterinary College, North Mymms, Herts, UK. FAU - Bryant, C E AU - Bryant CE FAU - Froling, I L AU - Froling IL FAU - Elliott, J AU - Elliott J FAU - Lees, P AU - Lees P LA - eng GR - Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Equine Vet J JT - Equine veterinary journal JID - 0173320 RN - 0 (Glucocorticoids) RN - 0 (Interleukin-1) RN - 0 (Lipopolysaccharides) RN - 0 (Nitrites) RN - 31C4KY9ESH (Nitric Oxide) RN - 7S5I7G3JQL (Dexamethasone) RN - EC 1.14.13.39 (Nitric Oxide Synthase) SB - IM CIN - Equine Vet J. 1997 Mar;29(2):86-7. PMID: 9104555 MH - Animals MH - Blotting, Western/methods/veterinary MH - Cartilage, Articular/*cytology/drug effects/*metabolism MH - Cells, Cultured MH - Dexamethasone/pharmacology MH - Dose-Response Relationship, Drug MH - Glucocorticoids/pharmacology MH - Horses/*metabolism MH - Interleukin-1/pharmacology MH - Isomerism MH - Lipopolysaccharides/pharmacology MH - Nitric Oxide/*biosynthesis MH - Nitric Oxide Synthase/metabolism MH - Nitrites/metabolism MH - Synovial Membrane/cytology/drug effects/metabolism MH - Time Factors EDAT- 1997/03/01 00:00 MHDA- 1997/03/01 00:01 CRDT- 1997/03/01 00:00 PHST- 1997/03/01 00:00 [pubmed] PHST- 1997/03/01 00:01 [medline] PHST- 1997/03/01 00:00 [entrez] AID - 10.1111/j.2042-3306.1997.tb01649.x [doi] PST - ppublish SO - Equine Vet J. 1997 Mar;29(2):98-102. doi: 10.1111/j.2042-3306.1997.tb01649.x.